About
This webinar will focus on a critical aspect of Multiple Sclerosis (MS) management – the de-escalation and discontinuation of Disease-Modifying Therapies (DMTs). In this session, our expert speakers will address the crucial questions of why, when, and how to make these strategic decisions. This webinar will offer a range of different views on de-escalation and discontinuation of DMTs.
Participants will gain valuable insights into tailoring MS treatment plans to individual patient needs, minimising risks, and optimising outcomes. Stay at the forefront of clinical practice by exploring the latest research and best practices in this complex yet vital aspect of MS care.
Webinar Faculty
• Moderator: Prof. Bruno Stankoff: Sorbonne University
• Speaker: Dr. Elisabeth Maillart: University Hospitals Pitié Salpêtrière – Charles Foix
• Speaker: Prof. Fredrik Piehl: Karolinska Institutet